Pharmaceutical Technology on MSN
FDA rejects Regeneron’s pre-filled Eylea HD syringes amid filling facility woes
Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.
Fluphenazine decanoate 25mg/mL; syringe; vial; contains benzyl alcohol. Cardiovascular or renal disease. Pheochromocytoma. Seizures. Glaucoma. History of breast cancer. Exposure to extreme heat or ...
Details: Lifecore will have a significant business development and marketing presence, including hosting booth meetings with existing and prospective customers and partners. Details: Lifecore will ...
CHASKA, Minn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback